Pharma-biotech partnerships take on new urgency as patent cliffs loom
Clarivate
MAY 31, 2023
Dependency on dealmaking Pharma has always relied on external innovation, through partnerships, licensing or acquisitions, to access the forefront of innovative technologies and biologics. of AbbVie’s $51.8 billion in revenue to a whopping 67.2% for Bristol Myers Squibb’s $44.7 billion based on seven preclinical ADC candidates.
Let's personalize your content